Sally W. Schwarz

Washington University in St. Louis — United States

Medicine · Health Sciences

19h-index1.9kcitations69works1.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(34), Medical Imaging Techniques and Applications(33), Medical Imaging and Pathology Studies(9), Monoclonal and Polyclonal Antibodies Research(7), Radioactive Decay and Measurement Techniques(5)

Publications68 total

FDA Investigator Training for PET Drug Manufacturing Inspections
Journal of Nuclear Medicine·2025
Proceedings: PET Drugs—A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit–Risk Considerations
Journal of Nuclear Medicine·2025· 2 citedOpen Access
Reply to “Foregoing Nonclinical Dosimetry Studies to Support First-in-Human Studies of Certain PET Radiopharmaceuticals”
Journal of Nuclear Medicine·2025
FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals
Journal of Nuclear Medicine·2025· 3 cited
#27. First-in-human evaluation of safety and dosimetry of 64Cu-LLP2A for PET imaging
Journal of bone oncology·2024· 2 citedOpen Access
[18F]Tosyl fluoride as a versatile [18F]fluoride source for the preparation of 18F-labeled radiopharmaceuticals
Scientific Reports·2023· 8 citedOpen Access
Characteristics and quantitative impact of off‐target skull binding in tau PET studies of Alzheimer disease
Alzheimer s & Dementia·2022· 3 cited
Characteristics and quantitative impact of off‐target skull binding in tau PET studies of Alzheimer disease
Alzheimer s & Dementia·2022
First-in-Humans Evaluation of Safety and Dosimetry of<sup>64</sup>Cu-LLP2A for PET Imaging
Journal of Nuclear Medicine·2022· 24 citedOpen Access
Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
Journal of Nuclear Medicine·2022· 17 citedOpen Access
The Development of <sup>18</sup>F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1
Radiology Imaging Cancer·2022· 23 citedOpen Access
Determination of molar activity of [18F]fluoride by HPLC via sulfonyl derivatization
Applied Radiation and Isotopes·2021· 4 cited
The Regulatory Process for Imaging Agents and Devices
Molecular Imaging·2021· 1 citedOpen Access
Beyond FDG: Novel Radiotracers for PET Imaging of Melanoma and Sarcoma
2020· 2 cited
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative Project
Journal of Nuclear Medicine·2020· 59 citedOpen Access
PDG72 KEY CRITERIA FOR ACCEPTANCE OF INDIRECT COMPARISONS IN THE BENEFIT ASSESSMENT BY THE G-BA AND BY THE IQWIG
Value in Health·2019Open Access
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
EJNMMI Radiopharmacy and Chemistry·2019· 17 citedOpen Access
Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?
Journal of Nuclear Medicine·2018· 24 citedOpen Access
Perspective on How the FDA Should Review Diagnostic Radiopharmaceuticals
Journal of Nuclear Medicine·2018· 8 citedOpen Access
Future cancer research priorities in the USA: a Lancet Oncology Commission
The Lancet Oncology·2017· 203 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Carolyn J. Anderson(10), Farrokh Dehdashti(7), Paul Cutler(7), Gordon W. Philpott(7), Judith M. Connett(7), Michael J. Welch(7), Henry F. VanBrocklin(5), Richard Laforest(4), Jason S. Lewis(4), Kurt R. Zinn(4), Li Guo(4), Reiko Oyama(4), Claude F. Meares(3), Barry A. Siegel(3), Pamela A. Rocque(3), Buck E. Rogers(3), Dong Zhou(3), John A. Katzenellenbogen(3), Clemens Decristoforo(3), Jennifer B. Frye(3)